Expression studies of CLN3 protein (Battenin) in fusion with the green fluorescent protein in mammalian cells in vitro

被引:33
作者
Golabek, AA
Kaczmarski, W
Kida, E
Kaczmarski, A
Michalewski, MP
Wisniewski, KE
机构
[1] New York State Inst Basic Res Dev Disabil, Dept Pathol Neurobiol, Staten Isl, NY 10314 USA
[2] Polish Acad Sci, Med Res Ctr, Dept Neuropathol, PL-02093 Warsaw, Poland
[3] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
关键词
CLN3; Batten disease; in vitro expression; GFP;
D O I
10.1006/mgme.1999.2836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The gene for Batten disease, the CLN3 gene, encodes a novel, highly hydrophobic, multitransmembrane protein, predicted to consist of 438 amino acid residues. We have expressed a full-length CLN3 protein in fusion with green fluorescent protein in various cell lines to provide its initial biochemical characterization and subcellular localization. By using Western blotting, Percoll density gradient fractionation, and Triton X-114 extraction, we demonstrate that the product of the CLN3 gene, which we call battenin, in mammalian expression system studied is a highly glycosylated protein of lysosomal membrane. In addition our data suggest that CLN3 protein is processed proteolytically in acidic compartments of the cell. Thus, battenin represents the novel constituent of a growing family of lysosomal membrane proteins. (C) 1999 Academic Press.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 15 条
  • [1] BORDIER C, 1981, J BIOL CHEM, V256, P1604
  • [2] GRANGER BL, 1990, J BIOL CHEM, V265, P12036
  • [3] Intracellular trafficking of lysosomal membrane proteins
    Hunziker, W
    Geuze, HJ
    [J]. BIOESSAYS, 1996, 18 (05) : 379 - 389
  • [4] A model for Batten disease protein CLN3: Functional implications from homology and mutations
    Janes, RW
    Munroe, PB
    Mitchison, HM
    Gardiner, RM
    Mole, SE
    Wallace, BA
    [J]. FEBS LETTERS, 1996, 399 (1-2) : 75 - 77
  • [5] Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
    Järvelä, I
    Sainio, M
    Rantamäki, T
    Olkkonen, VM
    Carpén, O
    Peltonen, L
    Jalanko, A
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (01) : 85 - 90
  • [6] Expression studies of CLN3 protein
    Kaczmarski, W
    Kida, E
    Lach, A
    Rubenstein, R
    Zhong, N
    Wisniewski, KE
    [J]. NEUROPEDIATRICS, 1997, 28 (01) : 33 - 36
  • [7] Katz ML, 1997, INVEST OPHTH VIS SCI, V38, P2375
  • [8] ISOLATION OF A NOVEL GENE UNDERLYING BATTEN-DISEASE, CLN3
    LERNER, TJ
    BOUSTANY, RMN
    ANDERSON, JW
    DARIGO, KL
    SCHLUMPF, K
    BUCKLER, AJ
    GUSELLA, JF
    HAINES, JL
    KREMMIDIOTIS, G
    LENSINK, IL
    SUTHERLAND, GR
    CALLEN, DF
    TASCHNER, PEM
    DEVOS, N
    VANOMMEN, GJB
    BREUNING, MH
    DOGGETT, NA
    MEINCKE, LJ
    LIU, ZY
    GOODWIN, LA
    TESMER, JG
    MITCHISON, HM
    ORAWE, AM
    MUNROE, PB
    JARVELA, IE
    GARDINER, RM
    MOLE, SE
    [J]. CELL, 1995, 82 (06) : 949 - 957
  • [9] Spectrum of mutations in the Batten disease gene, CLN3
    Munroe, PB
    Mitchison, HM
    ORawe, AM
    Anderson, JW
    Boustany, RM
    Lerner, TJ
    Taschner, PEM
    deVos, N
    Breuning, MH
    Gardiner, RM
    Mole, SE
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) : 310 - 316
  • [10] BIOGENESIS OF LYSOSOMAL MEMBRANES
    PETERS, C
    VONFIGURA, K
    [J]. FEBS LETTERS, 1994, 346 (01) : 108 - 114